Tumor cell responses to IFNγ affect tumorigenicity and response to IL- 12 therapy and antiangiogenesis

Immunity

Volumn 9, Issue 1, 1998, Pages 25-34

  Coughlin, Christina M ^a   Salhany, Kevin E ^a   Gee, Michael S ^a   LaTemple, Denise C ^a   Kotenko, Serguei ^b   Ma, XiaoJing ^c   Gri, Giorgia ^c   Wysocka, Maria ^c   Kim, Ji Eun ^a   Liu, Li ^d   Liao, Fang ^e   Farber, Joshua M ^e   Pestka, Sidney ^b   Trinchieri, Giorgio ^c   Lee, William M F ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c WISTAR INSTITUTE   (United States)

^d BD Technologies   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12;

ANGIOGENESIS; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR; TUMOR BLOOD FLOW; TUMOR CELL;

EID: 17344383269     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80585-3     Document Type: Article

References (37)

1. Angiolillo, A.L., Sgdari, C., Taub, D.D., Liao, F., Farber, J.M., Kleinmann, H.K., Reaman, G.H., and Tosato, G. (1995). Human Interferon inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med. 182, 155-162.
2. Boehm, U., Klamp, T., Groot, M., and Howard, J.C. (1997). Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15, 749-795.
3. Brunda, M.J., Luistro, L., Warrier, L.L., Wright, R.B., Hubbard, B.R., Murphy, M., Wolf, S.F., and Gately, M.K. (1993). Anti-tumor and anti-metastatic activity of IL-12 against murine tumors. J. Exp. Med. 178, 1223-1230.
4. Church, G.M., and Gilbert, W. (1984). Genomic sequencing. Proc. Natl. Acad. Sci. USA 81, 1991-1995.
5. Coughlin, C.M., Wysocka, M., Kurzawa, H.L., Lee, W.M.F., Trinchieri, G., and Eck, S.L. (1995). B7-1 and interleukin-12 synergistically induce effective antitumor immunity. Cancer Res. 55, 4980-4987.
6. Coughlin, C.M., Salhany, K.E., Wysocka, M., Arua, E., Kurzawa, H., Chang, A.E., Hunter, C.A., Fox, J.C., Trinchieri, G., and Lee, W.M.F. (1998). Interleukin 12 and interleukin 18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J. Clin. Invest. 101, 1441-1452.
7. Darnell, J.E., Jr., Kerr, I.M., and Stark, G.R. (1994). Jak-Stat pathways and transcriptional activation in response to interferons and other extracellular signaling proteins. Science 264, 1415-1421.
8. Decker, T., Kovarik, P., and Meinke, A. (1997). GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J. Interferon Cytokine Res. 17, 121-134.
9. Dighe, A.S., Farrar, M.A., and Schreiber, R.D. (1993). Inhibition of cellular responsiveness to interferon-gamma induced by overexpression of inactive forms of the IFN-gamma receptor. J. Biol. Chem. 268, 10645-10653.
10. Dighe, A.S., Richards, E., Old, L.J., and Schreiber, R.D. (1994). Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFNγ receptors. Immunity 1, 447-456.
11. Gately, M.K., Wolitzky, A.G., Quinn, P.M., and Chizzonite, R. (1992). Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell. Immunol. 143, 127-142.
12. Goldman, L.A., Cutrone, E.C., Kotenko, S.V., Krause, C.D., and Langer, J.A. (1996). Modification of vectors pEF-BOS, pcDNA-1, pcDNA-3 result in improved convenience and expression. BioTechniques 21, 1013-1015.
13. Gray, P.W., Leong, S., Fennie, E.H., Farrar, M.A., Pingel, J.T., Fernandez-Luna, J., and Schreiber, R.D. (1989). Cloning and expression of the cDNA for the murine IFNγ receptor. Proc. Natl. Acad. Sci. USA 86, 8497-8501.
14. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547-550.
15. Kleinman, H.K., McGarvey, M.L., Liotta, L.A., Robey, P.G., Tryggvason, K., and Martin, G.R. (1982). Isolation and characterization of type IV procollagen, laminin, and heparin sulfate proteoglycan from the EHS sarcoma. Biochemistry 21, 6188-6193.
16. Kobayashi, M., Fitz, L., Ryan, M., Hewick, R.M., Clark, S.C., Chan, S., Loudon, R., Sherman, F., Perussia, B., and Trinchieri, G. (1989). Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170, 827-846.
17. Kotenko, S.V., Izotova, L.S., Pollack, B.P., Mariano, T.M., Donnelly, R.J., Muthukumaran, G., Ook, J.R., Garotta, G., Silvennoinen, O., Ihle, J.N., and Pestka, S. (1995). Interaction between the components of the interferon-g receptor complex. J. Biol. Chem. 270, 20915-20921.
18. Kotenko, S., Izotova, L.I., Pollack, B.P., Muthukumaran, G., Paukku, K., Silvennoinen, O., Ihle, J.N., and Pestka, S. (1996). Other kinases can substitute for Jak2 in the signal transduction by Interferon-γ. J. Biol. Chem. 271, 17174-17182.
19. Kripke, M. (1979). Speculations on the role of ultraviolet radiation in the development of malignant melanoma. J. Natl. Cancer Inst. 63, 541-545.
20. Kurzawa, H., Wysocka, M., Aruga, E., Chang, A.E., Trinchieri, G., and Lee, W.M.F. (1998). Recombinant interleukin 12 enhances cellular immune responses to vaccination only after aperiod of suppression. Canc. Res. 55, 491-499.
21. Luster, A.D, and Leder, P. (1993). IP-10, a-C-X-C-chemokine, elicits a potent thymus-dependent anti-tumor response in vivo. J. Exp. Med. 178, 1057-1065.
22. McMaster, G.K., and Carmichael, G.C. (1977). Analysis of single and double stranded nucleic acids on polyacylamide and agarose gels by using glyoxal and acridine orange. Proc. Natl. Acad. Sci. USA 74, 4835-4838.
23. + T lymphocytes. J. Immunol. 151, 2444-2452.
24. Miller, A.D., and Rosman, G.J. (1989). Improved retroviral vectors for gene transfer and expression. BioTechniques 7, 980-987.
25. Nastala, C.L., Edington, H.D., McKinney, T.G., Tahara, H., Nalesnik, M.A., Brunda, M.J., Gately, M.K., Wolf, S.F., Schreiber, R.D., Storkus, W.J., and Lotze, MT. (1994). Recombinant IL-12 administration induces tumor regression in association with IFNγ production. J. Immunol. 153, 1697-1706.
26. Passaniti, A., Taylor, R.M., Pili, R., Guo, R., Long, P.V., Haney, J.A., Grant, D.S., and Martin, G.R. (1992). A simple quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin and fibroblastic growth factor. Lab. Invest. 67, 519-528.
27. Pearse, R.N., Feinman, R., Shuai, K., Darnell, J.E., and Ravetch, J.V. (1993). Interferon-gamma-induced transcription of the high-affinity Fc receptor for IgG requires assembly of the complex that includes the 91 kDa subunit of transciption factor ISGF3. Proc. Natl. Acad. Sci. USA 90, 4314-4318.
28. Schmitt, M., Ikeda, H., Nagata, Y., Gu, X., Wang, L., Kuribayashi, K., and Shiku, H. (1997). Involvement of T cell subsets and natural killer (NK) cells in the growth suppression of murine fibrosarcoma cells transfected with interleukin-12 (IL-12) genes. Int. J. Cancer 72, 505-511.
29. Sgadari, C., Angiolillo, A.L., and Tosato, G. (1996). Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein-10. Blood 87, 3877-3882.
30. Sgadari, C., Farber, J.M., Angiolillo, A.L., Liao, F., Teryua-Feldstein, J., Burd, P.R., Yao, L., Gupta, G., Kanegane, C., and Tosato, G. (1997). Mig, the monokine induced by interferon-γ, promotes tumor necrosis in vivo. Blood 89, 2635-2643.
31. Song, C.W., Kang, M.S., Rhee, J.G., and Levitt, S.H. (1994). Vascular damage and delayed cell death in tumors after hyperthermia. Br. J. Cancer 41, 309-312.
32. Streiter, R.M., Polverini, P.J., Arenberg, D.A., and Kunkel, S.K. (1995). The role of CXC chemokines as regulators of angiogenesis. Shock 4, 155-165.
33. Tan, J., Newton, C.A., Djeu, J.Y., Gutsch, D.E., Chang, A.E., Yang, N.S., Klein, T.W., and Hua, Y. (1996). Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model. Cancer Res. 56, 3399-3403.
34. Townsend, S.E., Su, F.W., Atherton, J.M., and Allison, J.P. (1994). Specificity and longevity of anti-tumor immune responses induced by B7-transfected tumors. Cancer Res. 54, 6477-6483.
35. Vanguri, P., and Farber, J.M. (1990). Identification of CRG-2. An interferon-inducible mRNA predicted to encode a murine monokine. J. Biol. Chem. 265, 15049-15057.
36. Voest, E.E., Kenyon, B.M., O'Reilly, M.S., Truitt, G., D'Amato, R.J., and Folkman, J. (1995). Inhibition of angiogenesis in vivo by interleukin-12. J. Natl. Cancer Inst. 87, 581-586.
37. Yeilding, N.M., Rehman, M.T., and Lee, W.M.F. (1996). Identification of sequences in c-myc mRNA that regulate its steady state levels. Mol. Cell. Bio. 16, 3511-3522.